Results 331 to 340 of about 2,771,911 (398)

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Corrigendum: Codon usage is influenced by compositional constraints in genes associated with dementia. [PDF]

open access: yesFront Genet
Alqahtani T   +7 more
europepmc   +1 more source

Editorial Expression of Concern: mtDNA structure: the women who formed the Brazilian northeast. [PDF]

open access: yesBMC Ecol Evol
Schaan AP   +13 more
europepmc   +1 more source

Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: Results from EMBRACE

open access: yes
Mavaddat N   +33 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy